Clinical Trials Browser

Phase 2 × idecabtagene vicleucel × 90 days × Clear all

NCT03601078 2026-03-04

KarMMa-2

Phase 2 Completed

Multiple Myeloma, Recurrence

NCT05393804 2026-02-17

A Study of Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell Transplant

Phase 2 Recruiting

Multiple Myeloma